Blog

Beyond the RIN Score: Why DV200 is the Only Metric That Matters for FFPE RNA Sequencing

By Scientific Affairs Team, Signios

If you work with clinical biobanks or archived human tissues, you know that Formalin-Fixed, Paraffin-Embedded (FFPE) tissue blocks are a scientific goldmine. They hold decades of patient history, treatment outcomes, and clinical endpoints. However, trying to extract high-quality nucleic acids from them can feel like a fool’s errand.

For years, molecular biologists have relied on the RNA Integrity Number (RIN) to audit their samples before running an RNA-Seq experiment. But if you pass an FFPE-derived sample through an Agilent Bioanalyzer or TapeStation and expect a helpful RIN score, you will almost always be met with a demoralizing result: a flat, chaotic baseline and a score somewhere between 1.0 and 2.5.

In the past, a RIN score that low meant throwing the sample in the waste bin. Today, it simply means you are using the wrong metric. For archived transcriptomics, the RIN score is obsolete—and the DV200 value is the only metric that matters. Here is why.

Why the RIN Score Fails in FFPE Samples

To understand why the RIN score fails, we have to look at how it is calculated. The RIN algorithm evaluates the sharp, distinctive peaks of the 28S and 18S ribosomal RNA (rRNA) fractions. In pristine tissues or fresh frozen cells, these two massive ribosomal units make up the vast majority of total RNA. If they are intact, the algorithm safely assumes the surrounding messenger RNA (mRNA) is intact too.

pristine sample high RIN
Decision matrix workflow

Formalin preservation destroys this structure instantly. The fixation process introduces aggressive chemical cross-linking between proteins and nucleic acids. Later, when the tissue is baked, embedded in wax, and stored at ambient temperatures for years, atmospheric oxygen and moisture slowly shear the long RNA chains.

Because the 28S and 18S ribosomal subunits are physically large molecules, they are the first to fracture into smaller segments. Consequently, your bioanalyzer trace shows no distinct ribosomal peaks—just a broad, continuous smear of short fragments. The RIN algorithm sees this smear, assumes complete sample degradation, and automatically spits out a failing score of 2.0.

However, highly fragmented RNA is not the same as useless RNA.

Enter the DV200: Quantifying the Fragment Smear

Developed to salvage these exact clinical samples, the DV200 metric completely ignores the presence or absence of ribosomal peaks. Instead, it calculates a simple percentage: the proportion of RNA fragments that are longer than 200nt.

DV200 = Mass of RNA Fragments > 200nt.

Even if every single 28S and 18S ribosomal molecule in your sample has been degraded and fragmented, thousands of your coding mRNA segments may still be 250, 400, or 600 nucleotides long.

A fragment length of more than 200 nucleotides is the exact critical threshold required for modern random-primed library prep chemistries (like Takara SMART-Seq Total RNA) to successfully bind, perform template switching, and generate a readable sequencing library.

Reading the Smear: What Your DV200 Score Actually Means

When you receive an electropherogram smear analysis from your lab or core facility, your DV200 percentage dictates your project’s technical feasibility and required sequencing depth.

DV200​ Score Quality Tier Technical Strategy Expected Outcome
Greater than 50% Optimal / Medium Increase input mass; boost sequencing depth to 50–60M reads. Highly robust data; strong correlation with fresh frozen controls.
25% to 50% Partially Degraded Preserves enzyme concentrations for downstream chemistry. Successful transcript recovery; excellent differential expression tracking.
20% to 25% Heavily Fragmented Borderline support. Requires max input biomass and deep sequencing (80M+ reads). Captures major transcriptional shifts; higher duplication rates expected.
Less than 20% Severely Compromised Not recommended for standard pipelines. Extreme drop in library complexity; high risk of technical failure.

How Signios Bio Rescues Low DV200 Samples

At Signios Bio, our FFPE pipeline is explicitly built to transform low DV200 fragment smears into high-fidelity transcriptomic data. We don’t try to force fragmented samples through workflows built for pristine tissue.

  1. Random Hexamer Priming over Oligo-dT: Because your poly(A) tails are likely snapped off and floating as isolated fragments, we prime across the entire length of the broken segments using random hexamers. If a fragment is 250nt long, we will catch it and sequence it.
  2. Enzymatic Ribosomal Cleavage via ZapR: Traditional bead-based poly(A) capture fails on fragmented tissue, and standard bead-based rRNA depletion can inadvertently pull down valuable mRNA fragments bound to cross-linked proteins. Our pipeline solves this by using ZapR technology downstream. We copy all fragments to cDNA first, and then utilize hyper-specific molecular cutters to destroy only the cDNA fragments originating from ribosomal sequences. This preserves every precious clinical transcript.
  3. UMI De-biasing: Fragmented libraries require extra PCR cycles to generate enough material for the flow cell. To prevent the resulting amplification duplicates from warping your data, we tag every original molecule with an 8-nucleotide Unique Molecular Identifier (UMI) barcode. This lets our bioinformatic pipeline cleanly scrub out technical duplicates while leaving your true clinical expression data pristine.

The Takeaway for Biobank Researchers

Before you exclude an archived patient cohort from your next translational study due to poor RIN scores, look closer at the fragment distribution. Dust off your old TapeStation data or let our laboratory team run an initial quality assessment to pull the true DV200 values.

If more than 20% of those fragments clear the 200-nucleotide line, those blocks aren’t waste—they are ready for discovery.

Explore our bulk RNA sequencing service options